Researchers have mapped how gene activity shifts across more than 50 cell types in the gut of Crohn’s disease patients, using single-cell RNA sequencing. The study, published in Genetic Engineering News, introduces IBDverse—a publicly accessible resource characterizing each cell type and those whose activity changes in disease.
The analysis identifies specific cellular pathways and transcriptional alterations that may drive inflammation in Crohn’s. By capturing the molecular state of individual cells, the work provides a granular view of disease mechanisms not possible with bulk tissue studies.
The IBDverse resource is now open to the scientific community, enabling other researchers to explore cell-type-specific gene expression patterns. This could accelerate target discovery for therapies aimed at restoring normal gut function.
The study was led by an academic team, and the findings were reported by GEN - Genetic Engineering and Biotechnology News. No funding sources or conflicts of interest were disclosed in the provided source.
As an open database, IBDverse relies on continued community contributions and validation. Its utility will depend on integration with clinical data and functional studies to confirm whether the observed gene activity changes are causative or secondary to inflammation.